Codexis CDXS
NASDAQ CDXS
$1.58 -0.01 (-0.63%)
At close: Aug 20, 2026 · 4:00 PM EDT

Codexis (CDXS) Net Margin (2010 - 2026)

Codexis (CDXS) posted quarterly Net Margin of 57.08% for Q1 2026, up 21718.0% year-over-year from N/an in Q1 2025, and down 331.37% quarter-over-quarter from 24.67% in Q4 2025.

Codexis (CDXS) Net Margin (2010 - 2026) Analysis & Trends

Codexis' Net Margin history runs 17 years deep, the most recent figure standing at 57.08% for Q1 2026.

  • In Q1 2026, Net Margin rose 21718.0% year-over-year to 57.08%; the TTM figure through Mar 2026 stood at 40.96% (up 10851.0% YoY), while the FY2025 annual figure was 62.47%, up 4752.0% from the prior year.
  • Net Margin for Q1 2026 stood at 57.08%, down from 24.67% in the prior quarter.
  • The five-year high for Net Margin was 24.67% in Q4 2025, with the low at 376.29% in Q3 2023.
  • The 5-year median for Net Margin is 86.59% (2025), against an average of 131.24%.
  • The sharpest annual moves came in 2023 and 2026: Net Margin sank 34730 bps in 2023, then soared 21718 bps in 2026.
  • Codexis' Net Margin stood at 63.66% in 2022, then tumbled by 126 bps to 143.84% in 2023, then soared by 66 bps to 48.35% in 2024, then soared by 151 bps to 24.67% in 2025, then tumbled by 331 bps to 57.08% in 2026.
  • Business Quant data shows CDXS's Net Margin at 57.08% in Q1 2026, 24.67% in Q4 2025, and 228.05% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 30.23%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 31.16%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -539.31%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 13.90%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 12.74%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -3.12%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 12.09%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -16.51%
10 Codexis 143.86 Mn 88.95 Mn 11.40 Mn -80.49%

Historic Data

Download Data
DateValue
Jun 30, 2026 -80.49%
Mar 31, 2026 -57.08%
Dec 31, 2025 24.67%
Sep 30, 2025 -228.05%
Jun 30, 2025 -86.59%
Mar 31, 2025 -274.27%
Dec 31, 2024 -48.35%
Sep 30, 2024 -160.84%
Jun 30, 2024 -285.19%
Mar 31, 2024 -67.39%
Dec 31, 2023 -143.84%
Sep 30, 2023 -376.29%
Jun 30, 2023 -230.46%
Mar 31, 2023 -174.22%
Dec 31, 2022 -63.66%
Sep 30, 2022 -28.99%
Jun 30, 2022 -6.87%
Mar 31, 2022 -23.64%
Dec 31, 2021 -41.59%
Sep 30, 2021 6.10%